WO2002082052A2 - Blood testing device - Google Patents

Blood testing device Download PDF

Info

Publication number
WO2002082052A2
WO2002082052A2 PCT/US2002/008818 US0208818W WO02082052A2 WO 2002082052 A2 WO2002082052 A2 WO 2002082052A2 US 0208818 W US0208818 W US 0208818W WO 02082052 A2 WO02082052 A2 WO 02082052A2
Authority
WO
WIPO (PCT)
Prior art keywords
blood
testing device
blood testing
distal end
intermediate portion
Prior art date
Application number
PCT/US2002/008818
Other languages
French (fr)
Other versions
WO2002082052A3 (en
Inventor
William M. Trudeau
James W. Boulgarides
Original Assignee
B. Braun Medical Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2001/026666 external-priority patent/WO2002080763A2/en
Application filed by B. Braun Medical Inc. filed Critical B. Braun Medical Inc.
Priority to CA002443076A priority Critical patent/CA2443076A1/en
Priority to BR0208698-0A priority patent/BR0208698A/en
Priority to US10/474,082 priority patent/US20040116830A1/en
Priority to JP2002579774A priority patent/JP2005503538A/en
Priority to AU2002254330A priority patent/AU2002254330A1/en
Priority to EP02723558A priority patent/EP1411820A2/en
Publication of WO2002082052A2 publication Critical patent/WO2002082052A2/en
Publication of WO2002082052A3 publication Critical patent/WO2002082052A3/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/15003Source of blood for venous or arterial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150213Venting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150221Valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150236Pistons, i.e. cylindrical bodies that sit inside the syringe barrel, typically with an air tight seal, and slide in the barrel to create a vacuum or to expel blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150244Rods for actuating or driving the piston, i.e. the cylindrical body that sits inside the syringe barrel, typically with an air tight seal, and slides in the barrel to create a vacuum or to expel blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150358Strips for collecting blood, e.g. absorbent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150389Hollow piercing elements, e.g. canulas, needles, for piercing the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150503Single-ended needles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/08Ergonomic or safety aspects of handling devices
    • B01L2200/082Handling hazardous material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0663Whole sensors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/14Means for pressure control
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/06Valves, specific forms thereof
    • B01L2400/0605Valves, specific forms thereof check valves
    • B01L2400/0611Valves, specific forms thereof check valves duck bill valves
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/02Burettes; Pipettes
    • B01L3/021Pipettes, i.e. with only one conduit for withdrawing and redistributing liquids
    • B01L3/0217Pipettes, i.e. with only one conduit for withdrawing and redistributing liquids of the plunger pump type

Definitions

  • the practice of medicine frequently involves testing blood for the presence or amount of one or more than one constituent, such as glucose, cardiac enzymes or red cells, or testing blood to determine the level of one or more than one parameter, such as pH.
  • Such testing is often done while performing an intravascular access procedure by allowing blood from the distal end of an intravascular access apparatus to contact the end of a test strip, and then inserting the test strip into an appropriate test strip reader. This might be done, for example, by allowing blood to leak out of a catheter that has accessed the vascular structure, prior to attaching the intravenous fluid administration tubing, onto the test strip.
  • Another method of gaining access to a patient's blood is to force the blood out of the vascular access device onto the test strip.
  • intravascular access procedures are performed by emergency medical personnel or by paramedics under adverse environmental conditions, such as inclement weather. Further, intravascular access procedures are often performed by emergency medical personnel or by paramedics in moving vehicles. These conditions increase the possibility of inaccurate blood test results due to test strip contamination, and increase the risk of exposure of the emergency medical personnel or paramedics to pathogens present in the blood being tested. Therefore, it would be useful to have a device for testing blood conditions that decreases the possibility of inaccurate blood test results due to test strip contamination. Further, it would be useful to have a device for testing blood conditions that decreases the risk of exposure of healthcare providers to pathogens present in the blood.
  • a blood testing device for testing blood for the presence or for the amount of one or more than one constituent, or for testing blood to determine the level of one or more than one parameter, or for testing blood for a combination of the preceding.
  • the blood testing device comprises a proximal end of the blood testing device and a distal end of the blood testing device; an intermediate portion between the proximal end of the blood testing device and the distal end of the blood testing device; and a pressure compensation system to regulate the pressure in the intermediate portion; and the intermediate portion comprises a proximal end of the intermediate portion comprising one or more than one opening, a distal end of the intermediate portion and, between the proximal end of the intermediate portion and the distal end of the intermediate portion, comprises a hollow, central chamber surrounded by an outer wall.
  • the pressure compensation system comprises a distal portion between the proximal end of the blood testing device and the distal end of the blood testing device, an inner membrane separating the intermediate portion from the distal portion; and the distal portion comprises a proximal end of the distal portion and a distal end of the distal portion and, between the proximal end of the distal portion and the distal end of the distal portion, comprises a hollow, central chamber surrounded by an outer wall.
  • the pressure compensation system comprises a pressure compensation valve, which can be a duck bill valve.
  • the blood testing device further comprises a distal end cap at the distal end of the blood testing device comprising a first opening configured to receive a test strip.
  • a distal end cap at the distal end of the blood testing device comprising a first opening configured to receive a test strip.
  • the outer wall of the intermediate portion is generally cylindrical.
  • the outer wall of the distal portion is generally cylindrical.
  • the blood testing device further comprises a proximal portion between the proximal end of the blood testing device and the proximal end of the intermediate portion.
  • the proximal portion comprises a hollow, central chamber surrounded by an outer wall, and the proximal portion is configured to mate with a blood containing apparatus.
  • the blood containing apparatus is selected from the group consisting of a syringe and the introducer part of an intravascular access apparatus.
  • the outer wall of the proximal portion is generally cylindrical.
  • the hollow, central chamber of the intermediate portion and the hollow, central chamber of the distal portion comprise generally rectangular inferior parts that communicate with each other and that are configured to accept a test strip.
  • the hollow, central chamber of the distal portion further comprises one or more than one ridge axially along the proximal to distal axis.
  • the outer wall of the intermediate portion is substantially transparent.
  • the distal end cap is an integral part of the distal portion of the blood testing device.
  • the distal end cap is removably affixed to the distal portion of the blood testing device.
  • the distal end cap further comprises one or more than one second opening to allow the venting of air externally out of the distal portion of the blood testing device.
  • the inner membrane is a semipermeable member. In another embodiment, the inner membrane comprises one or more than one vent.
  • the outer wall of the intermediate portion comprises one or more than one vent.
  • the inner membrane comprises an opening configured to allow passage of a test strip from the distal portion of the blood testing device into the intermediate portion of the blood testing device.
  • the intermediate portion is integrally affixed to an introducer portion of an intravascular access apparatus.
  • the intermediate portion is configured to affix to an introducer portion of an intravascular access apparatus.
  • the distal end of the blood testing device is integrally affixed to a blood collection apparatus.
  • the distal end of the blood testing device is configured to affix to a blood collection apparatus.
  • the blood collection apparatus may be a syringe.
  • the intermediate portion is either integrally affixed or configured to affix to an introducer portion of an intravascular access apparatus, and the distal end is either integrally affixed or configured to affix to a blood collection apparatus.
  • the blood collection apparatus may be a syringe.
  • the present invention is a blood testing apparatus comprising a plurality of interconnected blood testing devices according to the present invention.
  • the present invention is a method for testing blood for the presence or for the amount of one or more than one constituent, or for testing blood to determine the level of one or more than one parameter, or for testing blood for a combination of the preceding.
  • the method comprises the steps of, first, providing a blood testing device according to the present invention, a test strip comprising a proximal end and a distal end, a test strip reader configured to accept the distal end of the test strip and a blood containing apparatus.
  • the blood testing device is affixed to the blood containing apparatus and blood present in the blood containing apparatus is allowed to enter into the intermediate portion of the blood testing device.
  • the distal end of the test strip is inserted into the test strip reader and the proximal end of the test strip is inserted into the intermediate portion of the blood testing device.
  • an operator uses information provided by the test strip reader to determine the presence or the amount of one or more than one constituent of the blood, or to determine the level of one or more than one parameter, or to determine a combination of the preceding.
  • the blood testing apparatus is selected from the group consisting of an intravascular access apparatus and a syringe.
  • the blood testing device and blood containing apparatus can be affixed integrally.
  • the method further comprises selecting a patient whose blood is to be tested and intravascularly accessing the patient's blood with the blood containing apparatus. In another embodiment, the method further comprises the step of discarding the blood testing device.
  • the one or more than one opening in the proximal end of the intermediate portion of the blood testing device comprises a flow valve.
  • this flow valve may be a duck-bill valve or a flap valve.
  • Figure 1 is a lateral perspective view of a blood testing device according to one embodiment of the present invention.
  • Figure 2 is a cross-sectional, lateral perspective view of the blood testing device shown in Figure 1;
  • Figure 3 is a lateral perspective view of a blood testing device shown in Figure 1 attached to a standard intravascular access apparatus;
  • Figure 4 is a lateral perspective view of a semipermeable membrane forming part of the blood testing device of Figure 1;
  • Figure 5 is a lateral perspective view of a blood testing device according to another embodiment of the present invention;
  • Figure 6 is a lateral perspective view of a blood testing device according to another embodiment of the present invention.
  • Figure 7 is a lateral perspective view of a blood testing device according to another embodiment of the present invention.
  • Figure 8 is a lateral perspective view of a blood testing apparatus comprising a plurality of interconnected blood testing devices according to the present invention
  • Figure 9 is a cross-sectional, lateral perspective view of the blood testing device shown in Figure 1 according to another embodiment of the present invention
  • Figure 10A is a cross-sectional view of a duck bill valve forming part of the blood testing device of Figure 6, before insertion of a test strip;
  • Figure 1 OB is a cross-sectional view of a duck bill valve forming part of the blood testing device of Figure 6, after insertion of a test strip;
  • Figure 11 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention.
  • Figure 12 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention.
  • Figure 13 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention
  • Figure 14 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention.
  • Figure 15 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention.
  • Figure 16 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention.
  • Figure 17 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention.
  • Figure 18 is a cross-sectional, lateral perspective view of another embodiment of the blood testing device shown in Figure 1.
  • a blood testing device for testing blood for the presence or for the amount of one or more than one constituent, such as glucose, cardiac enzymes or red cells, or for testing blood to determine the level of one or more than one parameter, such as pH, or for testing blood for a combination of the preceding.
  • the blood testing device decreases the possibility of inaccurate blood test results due to test strip contamination, and decreases the risk of exposing an operator to pathogens present in the blood.
  • a method for testing blood for the presence or for the amount of one or more than one constituent, such as glucose, cardiac enzymes or red cells, or for testing blood to determine the level of one or more than one parameter, such as pH, or for testing blood for a combination of the preceding comprises providing a testing means that decreases the possibility of inaccurate blood test results due to test strip contamination, and decreases the risk of exposing an operator to pathogens present in the blood.
  • FIG. 1 Figure 1 and Figure 3 there are shown, respectively, a lateral perspective view of a blood testing device 10 according to one embodiment of the present invention; a cross-sectional, lateral perspective view of a blood testing device 10 shown in Figure 1; and a lateral perspective view of a blood testing device 10 shown in Figure 1 combined with a intravascular access apparatus 100.
  • the blood testing device 10 comprises a proximal end 12 and a distal end 14. Between the proximal end 12 and the distal end 14, the blood testing device 10 further comprises a proximal portion 16, a distal portion 18, and an intermediate portion 20 between the proximal portion and the distal portion.
  • the proximal portion 16 comprises a proximal end 22 and a distal end 24 and, between the proximal end 22 and the distal end 24, further comprises a hollow, central chamber 26 surrounded by an outer wall 28 having a long axis in the proximal to distal direction.
  • the outer wall 28 of the proximal portion 16 is configured to mate with the distal end of a blood containing apparatus, such as a syringe (not shown) or the introducer part 102 of an intravascular access apparatus 100, as shown in Figure 3.
  • the outer wall 28 of the proximal portion 16 is configured to mate with the distal end of the introducer part of a standard intravascular access apparatus, such as an Introcan® SafetyTM IN Catheter (B.
  • the outer wall 28 of the proximal portion 16 will vary in configuration depending on the intravascular access apparatus that will be used in conjunction with the blood testing device 10 of the present invention, as will be understood by those with skill in the art with reference to this disclosure.
  • the outer wall 28 of the proximal portion 16 comprises a generally tapered proximal-most part 30 and a generally cylindrical distal-most part 32.
  • the proximal-most part 30 of the outer wall 28 preferably further comprises one or more than one opening 34 allowing the hollow, central chamber 26 to communicate externally, or when combined with a blood containing apparatus, to communicate with the blood containing part of the blood containing apparatus.
  • the one or more than one opening 34 is configured to allow the passage of blood that is present in the blood containing apparatus into the hollow, central chamber 26 of the proximal portion 16.
  • the intermediate portion 20 comprises a proximal end 36 and a distal end 38 and, between the proximal end 36 and the distal end 38, comprises a hollow, central chamber 40 surrounded by an outer wall 42 having a long axis in the proximal to distal direction.
  • the outer wall 42 of the intermediate portion 20 is generally cylindrical, though other configurations are also suitable, as will be understood by those with skill in the art with reference to this disclosure.
  • the proximal end 36 of the intermediate portion 20 comprises one or more than one opening 44 allowing the hollow, central chamber 40 of the intermediate portion 20 to communicate with the hollow, central chamber 26 of the proximal portion 16.
  • the passage of test strip 104 through the inner membrane 66 may create a small air leak that results in the encapsulated blood slowly dripping out of the proximal portion 16. This may be most evident if the hollow, central chamber40 completely fills with blood.
  • the one or more than one opening 44 may comprise a one-way flow valve 118 which permits blood to flow into the intermediate portion 20, but restricts blood from flowing back through the proximal portion 16. Any valve that restricts blood to a substantially one-way flow will function as optional flow valve 118. Examples of valves suitable for such use include a duck-bill valve, and a flap valve.
  • the distal portion 18 comprises a proximal end 48 and a distal end 46 and, between the proximal end 48 and the distal end 46, comprises a hollow, central chamber 50 surrounded by an outer wall 52 with a central axis in the proximal to distal direction.
  • the outer wall 52 of the distal portion 18 is generally cylindrical, though other configurations are also suitable, as will be understood by those with skill in the art with reference to this disclosure.
  • the hollow, central chamber 50 has a sufficient size and suitable shape to receive a test strip 104 or other test apparatus inserted into the hollow, central chamber 50 from the distal end 14 of the blood testing device 10 toward the proximal end 12.
  • test strip is understood to include other test apparatuses that are not in linear strip form but are suitable for use with the blood testing device 10 of the present invention. Therefore, the configuration of the hollow, central chamber 50 of the distal portion 18 will depend upon the configuration of the test strip to be used, as will be understood by those with skill in the art with reference to this disclosure. Suitable test strips include chemical test strips, such as One Touch® FastTake® (LifeScan, Inc., Milpitas, CA US) and electrochemical test strips, such as
  • the hollow, central chamber 50 of the distal portion 18, and the hollow, central chamber 40 of the intermediate portion 20 comprises generally rectangular (when viewed from an inferior direction), inferior part 54 and inferior part 56, respectively, as shown, that communicate with each other and that are configured to accept a test strip 104.
  • the proximal end 58 of the outer wall of the inferior part 56 of the intermediate portion 20 is closed.
  • inferior part 54 of central chamber 50 of distal portionl ⁇ further comprises one or more than one ridge 55 having a long axis in the proximal to distal direction. Ridge 55 acts a guide for test strip 104 in inferior part
  • Ridge 55 may extend for part or all of the length of central chamber 50, and may extend for part or all of the width of central chamber 50.
  • the outer wall 28 of the proximal portion 16, the outer wall 42 of the intermediate portion 20 and the outer wall 52 of the distal portion 18 preferably comprise a plastic material such as polycarbonate, that does not affect the constituents or parameters of blood being tested, though other materials are suitable as will be understood by those with skill in the art with reference to this disclosure.
  • the material used is preferably inexpensive, as the blood testing device 10 is intended to be discarded after a single use, and is capable of being manufactured into the proper shape according to standard techniques l ⁇ iown to those with skill in the art, such as by injection molding. Further preferably, the material is either substantially transparent or at least sufficiently transparent to allow visual confirmation that blood is present in the hollow, central chamber 40 of the intermediate portion 20.
  • the distal end 14 of the blood testing device 10 further comprises a distal end cap 60.
  • the distal end cap 60 is an integral part of the distal portion 18 of the blood testing device 10, and of the same or of a different material as the outer wall 52 of the distal portion 18.
  • the distal end cap 60 is a separate part, removable from the distal portion 18, and comprises a resilient material such as natural or synthetic rubber that, when placed over the distal portion 18 of the blood testing device 10, tends to remain attached to the distal portion 18 of the blood testing device 10 due to the resilient nature of the material.
  • the distal end cap 60 further comprises at least a first opening 62 configured to snugly receive a test strip 104 inserted into the hollow, central chamber 50 of distal portion 18 of the blood testing device 10. Therefore, the configuration of the first opening 62 in the distal end cap 60 will depend upon the configuration of the test strip to be used, as will be understood by those with skill in the art with reference to this disclosure.
  • the first opening 62 is generally slit-like, as shown in Figure 1, Figure 2 and Figure 3.
  • the first opening 62 can comprise a simple opening into the hollow, central chamber 50 of the distal portion 18, as shown, or can comprise a valve, such as a duck bill valve 65 as shown in Figure 10A and Figure 10B.
  • the distal portion 18 and the intermediate portion 20 each comprises the generally rectangular, inferior part 54 and 56 and the long axis of the first opening 62 is a slit that is aligned perpendicular to the direction of insertion of the long axis of the test strip 104 into the distal portion 18.
  • the distal end cap 60 can comprise a semipermeable membrane, as shown in Figure 11, that allows the selective passage of air out of the distal portion 18, while retaining the fluid and cellular components of blood within the distal portion 18.
  • the semipermeable membrane can comprise any suitable material, such as Porex T3 #X-7744, (Porex Medical Products Group, Fairburn, GA US) or Type TTTP Isopore Membrane (Millipore Corporation, Bedford, MA US), though other material is also suitable as will be understood by those with skill in the art with reference to this disclosure.
  • the distal end cap 60 comprises a vent of one or more than one second opening 64 to allow the venting of air externally out of the distal portion 18 of the blood testing device 10.
  • the second opening 64 can be any suitable configuration, such as generally slit-like, as shown in Figure 1, as will be understood by those with skill in the art with reference to this disclosure.
  • the outer wall 52 of the distal portion 18 can comprise one or more than one vent 53.
  • the blood testing device 10 further comprises an inner membrane 66 separating the distal end 38 of the hollow, central chamber 40 of the intermediate portion 20 from the proximal end 48 of the hollow, central chamber 50 of the distal portion 18.
  • the inner membrane 66 is a semipermeable member.
  • the inner membrane 66 is not permeable but comprises one or more than one vent (not shown). Alternately, or additionally, as shown in Figure 13 and Figure 15, the outer wall
  • the inner membrane 66 comprises any suitable material, such as rubber or Porex T3 #X-7744, (Porex Medical Products Group, Fairburn, GA US), and can additionally be treated to be hydrophobic, as will be understood by those with skill in the art with reference to this disclosure.
  • FIG 4 there is shown a lateral perspective view of one embodiment of an inner membrane 66 forming part of the embodiment of the blood testing device 10 shown in Figure 1, Figure 2 and Figure 3.
  • the inner membrane 66 allows the selective passage of air through the inner membrane 66 between the distal end 38 of the hollow, central chamber 40 of the intermediate portion 20 and the proximal end 48 of the hollow, central chamber 50 of the distal portion 18, while preventing the passage of the fluid and cellular components of blood through the inner membrane 66.
  • the inner membrane 66 is further configured to allow passage of the test strip 104 from the distal portion 18 of the blood testing device 10 into the intermediate portion 20 of the blood testing device 10.
  • the inner membrane 66 can comprise a slit 67 aligned with the first opening 62 in the distal end cap 60.
  • the inner membrane 66 can comprise a perforation (not shown) aligned with the first opening 62 in the distal end cap 60. In that embodiment the perforation can be constructed so that it is breached by the insertion of test strip 104.
  • the intermediate portion 20 and the distal portion 18 each comprise the generally rectangular, inferior part 54 and 56 and the first opening 62 is a slit that is aligned perpendicular to the direction of insertion of the long axis of the test strip 104 into the distal portion 18, and the inner membrane 66 has an inferior extension 68 that further divides the inferior part 54 of the distal portion 18 from the inferior part 56 of the intermediate portion 20.
  • the blood testing device 10 is manufactured without a proximal portion 16 and with the intermediate portion 20 integrally affixed to the distal end of the introducer part 102 of a standard intravascular access apparatus 100.
  • the blood testing device 10 and introducer part 102 of an intravascular access apparatus 100 are inserted intravascularly and are removed as a unit, as will be understood by those with skill in the art with reference to this disclosure.
  • the pressure within central chamber 50 will increase. If no pressure compensation system has been included in the blood testing device for amelioration of this pressure increase, depending upon the nature of the material chosen for the inner membrane 66, a corresponding increase in the pressure within the central chamber 40 of the intermediate portion 20 may result. If no pressure compensation system has been included for equalization of pressure within central chamber 40, a small amount of blood may be expelled through the one or more than one opening 34 of the proximal-most part 30 of outer wall 28 of proximal portion 16. This may be undesirable to the health care worker inserting the test strip. As the test strip is further inserted into inferior part 56 of the intermediate portion 20, an additional increase in pressure within central chamber 40 will occur, increasing the likelihood of escape of blood through opening 34.
  • a preferred embodiment of a pressure compensation system is as shown in Figure 1, Figure 2, and Figure 4, in which inner membrane 66 is a semipermeable member, comprising an inferior extension 68, and distal end cap 60 comprises a resilient material such as natural or synthetic rubber, and a vent of one or more than one second opening 64.
  • this embodiment of the pressure compensation system allows pressure to equalize, resulting in little escape of blood from the intermediate portion into the distal portion, and no escape of blood from the blood testing device 10.
  • central chamber 50 of distal portion 18 comprises one or more than one ridge 55 reducing the amount of blood that enters central chamber 50.
  • FIG. 11 Another embodiment of a pressure compensation system, as shown in Figure 11, comprises a distal end cap 60 comprising a semipermeable membrane that allows the selective passage of air out of the distal portion 18, together with inner membrane 66 being a semipermeable member, comprising an inferior extension 68.
  • second opening 64 is not required.
  • a pressure compensation system comprises a distal end cap 60 comprising an integral part of the distal portion 18 of the blood testing device 10, and of the same or of a different material as the outer wall 52 of the distal portion 18, together with inner membrane 66 being a semipermeable member, comprising an inferior extension 68.
  • second opening 64 is located either on the distal end cap, or one or more than one vent 53 is located on outer wall52.
  • a pressure compensation system comprises an inner membrane 66 which is not permeable but comprises one or more than one vent (not shown).
  • the outer wall 42 of the intermediate portion 20 can comprise one or more than one vent 43.
  • distal end cap 60 may optionally comprise (I) a resilient material such as natural or synthetic rubber, and a vent of one or more than one second opening 64 in the end cap, or the outer wall 52 of distal portion 18 can comprise one or more than one vent 53, (ii) a semipermeable membrane that allows the selective passage of air out of the distal portion 18, or (iii) an integral part of the distal portion 18 of the blood testing device 10, and of the same or of a different material as the outer wall 52 of the distal portion 18, and one or more than one second opening 64 in the end cap, or the outer wall 52 of distal portion 18 can comprise one or more than one vent 53.
  • the blood testing device 10 comprises a distal end cap 60 where the first opening 62 comprises a duck bill valve 65, shown in cross- section in Figure 10A before a test strip 104 is inserted, and shown in cross-section in Figure 10B after a test strip 104 is inserted, the sides of which adjoin and seal together when no test strip 104 is present and which separate upon insertion of a test strip to permit insertion of the test strip into the hollow, central chamber 40 of the intermediate portion 20.
  • a pressure compensation system In this embodiment of a pressure compensation system, the equalization of pressure is accomplished by the collapse of the structure of the duck bill valve, as is shown in Figure 10B after the test strip 104 is inserted, and as will be understood by those with skill in the art with reference to this disclosure. Accordingly, in this embodiment opening 64 in end cap 60 and inner membrane 66 are not needed. Having thus described several embodiments of a pressure compensation system, it will now be understood by those with skill in the art with reference to this disclosure that a pressure compensation system may be constructed with various combinations of the described components, as further shown in Figures 11 through 17.
  • FIG. 7 a lateral perspective view of a blood testing device 10 according to two other embodiments of the present invention.
  • the blood testing device 10 is manufactured integrally affixed to the side of a syringe 108 by connecting either the intermediate portion 20 of a blood testing device 10, as disclosed above, directly to the side of the syringe 108, as in Figure 7, or the inner membrane 66 directly to the side of the syringe 108, as in Figure 17, the interior of syringe 108 thus becoming the intermediate portion 20.
  • Other blood collection devices could be used, as will be understood by those with skill in the art with reference to this disclosure.
  • the syringe 108 is used to draw blood from a blood source and the blood testing device 10 is used to test the blood within the syringe 108 without having too expel the blood from the syringe 108.
  • the blood testing device 10 is used to test the blood within the syringe 108 without having too expel the blood from the syringe 108.
  • the plunger 10 can also be affixed to the distal end of the plunger of a syringe 108 where the plunger has a central channel in communication with the intermediate portion 20 of the blood testing device 10 (not shown).
  • the present invention includes a blood testing apparatus 110 comprising a plurality of interconnected blood testing devices 10 according to the present invention, to allow multiple test strips to be read from blood in the same blood containing apparatus 110.
  • a blood testing apparatus 110 comprises a proximal end 112 configured to mate with an intravascular access apparatus 100, a distal end 114 configured to mate with a syringe 108, a hollow, central chamber 116 between the proximal end and the distal end, and a plurality of blood testing devices 10 according to the present invention, each blood testing device 10 joined to the hollow, central chamber 116.
  • the distal end 114 is configured to mate with the proximal end of a standard flash plug or the proximal end of a syringe 108 (as shown).
  • This embodiment allows blood from one source to be tested using a plurality of blood testing devices 10 according to the present invention, as will be understood by those with skill in the art with reference to this disclosure.
  • blood testing device 10 takes the place of a standard flash plug, the proximal end 12 of blood testing device 10 is configured to mate with the introducer part 102 of a intravascular access apparatus 100, as shown in Figure 11, and additionally optionally the distal end 14 of blood testing device 10 may be configured to mate (not shown) integrally or removably with a blood collection device such as syringe 108.
  • a method for testing blood for the presence or for the amount of various constituents, such as glucose, cardiac enzymes or red cells, or for testing blood to determine the level of various parameters, such as pH, or for testing blood for a combination of the preceding comprises providing a blood testing device according to the present invention.
  • the method additionally comprises providing a test strip, a test strip reader and a blood containing apparatus, such as an intravascular access apparatus or a syringe.
  • the test strip can be any suitable test strip with a proximal end configured to be inserted into the distal end cap of the blood testing device.
  • the test strip reader can be any suitable test strip reader configured to accept the distal end of the test strip and, after accepting the distal end, to provide the desired information on blood that has contacted the proximal end of the test strip.
  • the blood containing apparatus can be any intravascular access apparatus suitable for accessing a vascular structure and suitable for joining to the proximal end of a blood testing device according to the present invention, or any other suitable blood containing apparatus as will be understood by those with skill in the art with reference to this disclosure.
  • the blood testing device can be provided with or without the test strip inserted through the distal end cap and into the distal portion and intermediate portion of the blood testing device.
  • the blood testing device is provided with the test strip inserted through the distal end cap and into the distal portion and intermediate portion of the blood testing device, then the combined blood testing device and test strip can be provided with the distal end of the test strip already inserted into the test strip reader. Further, the blood testing device, whether or not combined with the test strip or with the test strip and test strip reader together, can be provided having its proximal end already inserted into the distal end of the blood containing apparatus or can be provided without its proximal end already inserted into the distal end of the blood containing apparatus. As will be understood by those with skill in the art with reference to this disclosure, the blood containing apparatus, blood testing device, test strip and test strip reader are assembled together during the method of the present invention, and can be assembled in various orders.
  • the distal end of the test strip is inserted into the test strip reader, and then the proximal end of the test strip is inserted into the distal end cap of the blood testing device and through or around the inner membrane after blood has entered the intermediate portion of the blood testing device.
  • a patient is selected who is to have his or her blood tested. If the blood containing apparatus is an intravascular access apparatus, the patient is prepped in a standard manner and intravascular access is begun using the intravascular access apparatus according to standard techniques, as will be understood by those with skill in the art with reference to this disclosure. If the proximal end of the blood testing device was not already inserted into the distal end of the intravascular access apparatus before obtaining intravascular access, then the proximal end of the blood testing device is inserted into the distal end of the intravascular access apparatus, such as by replacing the flash plug on the intravascular access apparatus with the proximal portion of the blood testing device.
  • the proximal end of the blood testing device is inserted into the distal end of the intravascular access apparatus before insertion of the intravascular access apparatus.
  • a blood testing device is provided according to the present invention, without a proximal portion and with the intermediate portion integrally affixed to the distal end of the introducer portion of a standard intravascular access apparatus.
  • blood from the patient's accessed vascular structure will pass through the one or more than one opening in the proximal end of the proximal portion into the hollow, central chamber of the proximal portion and, then, into the hollow, central chamber of the intermediate portion, or will pass directly into the hollow, central chamber of the intermediate portion if the blood testing device is integrally affixed to the intravascular access apparatus.
  • Air that is present in the hollow, central chamber of the proximal portion, if present, and hollow, central chamber of the intermediate portion passes through the inner membrane into the hollow, central chamber of the distal portion and then, externally.
  • the distal end of the test strip is inserted into the test strip reader and the proximal end of the test strip is inserted into the distal end cap, through the distal portion and into the intermediate portion of the blood testing device.
  • the blood in the hollow, central chamber of the intermediate portion will, then, contact the proximal end of the test strip.
  • the distal end of the test strip is inserted into an appropriate test strip reader, if not done previously.
  • the operator uses information provided by the test strip reader, such as a digital readout or visual indicator, to determine the presence or the amount of one or more than one constituent of the blood, such as glucose, cardiac enzymes or red cells, or to determine the level of one or more than one parameter, such as pH, or to determine a combination of the preceding.
  • the operator withdraws the blood testing device from the distal end of the intravascular access apparatus before using the test strip reader.
  • the blood testing device with an inserted test strip is removed from the intravascular access apparatus and an operator proceeds to establish intravascular access while the distal end of the test strip is being inserted into an appropriate testing apparatus, so that no time is being lost in establishing intravascular access while blood testing is being performed.
  • the introducer part of the intravascular access apparatus with the blood testing device still inserted into the distal end are removed together, and an operator proceeds to establish intravascular access while the proximal end of the test strip is being inserted into distal end of the blood testing device, further increasing efficiency in establishing intravascular access while blood testing is being performed.
  • the blood testing device provided for use in this method is the embodiment shown in Figure 5, and as will be understood by those with skill in the art with reference to this disclosure, removing the blood testing device necessarily removes the introducer part of the intravascular access apparatus from the vascular structure as the blood testing device is integrally affixed to the distal end of the introducer part of the intravascular access apparatus. After the operator makes the appropriate determinations, the blood testing device with the test strip still inserted is removed from the test strip reader and, preferably with the introducer portion if being used with an introducer portion, is discarded in an appropriate manner as a biohazard.
  • the present method decreases the possibility of inaccurate blood test results due to test strip contamination, decreases the time necessary to analyze blood being tested from standard methods, decreases the risk of exposure of the operator to pathogens present in the blood, and simplifies disposal of the equipment used in testing the blood.
  • a method for testing blood for the presence or for the amount of various constituents, such as glucose, cardiac enzymes or red cells, or for testing blood to determine the level of various parameters, such as pH, or for testing blood for a combination of the preceding comprises providing a blood testing apparatus according to the present invention, where the blood testing apparatus comprises a plurality of blood testing devices according to the present invention joined to a common central chamber that is configured at the proximal end to combine removably or to be affixed with a blood containing apparatus, and to communicate with the blood containing part of the blood containing apparatus.
  • the method corresponds to the method disclosed above, except that blood test strips can be inserted into the distal end caps of each blood testing device on the blood testing apparatus, expanding the capacity to test the blood.
  • a method for testing blood for the presence or for the amount of various constituents, such as glucose, cardiac enzymes or red cells, or for testing blood to determine the level of various parameters, such as pH, or for testing blood for a combination of the preceding comprises using a blood containing apparatus, such as a syringe, other than an intravascular access apparatus.
  • blood is drawn into the blood containing apparatus other than by obtaining intravascular access directly through the distal end of the blood containing apparatus, such as by attaching the blood containing apparatus directly to an intravascular access apparatus or blood containing vial and drawing blood into the blood containing apparatus from that source.

Abstract

A blood testing device (10) comprising a proximal end (12) and a distal end (14); an intermediate portion (20) between the proximal end (12) and the distal end (14); a pressure compensation system to regulate the pressure in the intermediate portion (20), and a distal end cap (60) at the distal end (14) comprising a first opening (62) configured to receive a test strip (104). The intermediate portion (20) comprises a proximal end (36) comprising one or more than one opening (44), a distal end (38) of the intermediate portion (20) and, between the proximal end (36) and the distal end (38), comprises a hollow, central chamber (40) surrounded by an outer wall (42). The one or more than one opening (44) may optionally comprise a flow valve (118).

Description

BLOOD TESTING DEVICE
CROSS-REFERENCE TO RELATED APPLICATIONS
The present Application claims the benefit of United States Provisional Patent Application Ser. No. 60/281,957 titled "Unidirectional Self-sealing Blood Testing Apparatus," filed April 6, 2001; and International Application Ser. No. PCT/US01/26666, filed August 24, 2001; the contents of which are incorporated by reference in this disclosure in their entirety.
BACKGROUND The practice of medicine frequently involves testing blood for the presence or amount of one or more than one constituent, such as glucose, cardiac enzymes or red cells, or testing blood to determine the level of one or more than one parameter, such as pH. Such testing is often done while performing an intravascular access procedure by allowing blood from the distal end of an intravascular access apparatus to contact the end of a test strip, and then inserting the test strip into an appropriate test strip reader. This might be done, for example, by allowing blood to leak out of a catheter that has accessed the vascular structure, prior to attaching the intravenous fluid administration tubing, onto the test strip. Another method of gaining access to a patient's blood is to force the blood out of the vascular access device onto the test strip.
Frequently, however, intravascular access procedures are performed by emergency medical personnel or by paramedics under adverse environmental conditions, such as inclement weather. Further, intravascular access procedures are often performed by emergency medical personnel or by paramedics in moving vehicles. These conditions increase the possibility of inaccurate blood test results due to test strip contamination, and increase the risk of exposure of the emergency medical personnel or paramedics to pathogens present in the blood being tested. Therefore, it would be useful to have a device for testing blood conditions that decreases the possibility of inaccurate blood test results due to test strip contamination. Further, it would be useful to have a device for testing blood conditions that decreases the risk of exposure of healthcare providers to pathogens present in the blood.
SUMMARY In one embodiment, there is provided a blood testing device for testing blood for the presence or for the amount of one or more than one constituent, or for testing blood to determine the level of one or more than one parameter, or for testing blood for a combination of the preceding. The blood testing device comprises a proximal end of the blood testing device and a distal end of the blood testing device; an intermediate portion between the proximal end of the blood testing device and the distal end of the blood testing device; and a pressure compensation system to regulate the pressure in the intermediate portion; and the intermediate portion comprises a proximal end of the intermediate portion comprising one or more than one opening, a distal end of the intermediate portion and, between the proximal end of the intermediate portion and the distal end of the intermediate portion, comprises a hollow, central chamber surrounded by an outer wall.
In one preferred embodiment, the pressure compensation system comprises a distal portion between the proximal end of the blood testing device and the distal end of the blood testing device, an inner membrane separating the intermediate portion from the distal portion; and the distal portion comprises a proximal end of the distal portion and a distal end of the distal portion and, between the proximal end of the distal portion and the distal end of the distal portion, comprises a hollow, central chamber surrounded by an outer wall. In another preferred embodiment, the pressure compensation system comprises a pressure compensation valve, which can be a duck bill valve.
In one embodiment, the blood testing device further comprises a distal end cap at the distal end of the blood testing device comprising a first opening configured to receive a test strip. Embodiments are described using an end cap that is a semi-permeable member, and a non-permeable member.
In another embodiment, the outer wall of the intermediate portion is generally cylindrical.
In another embodiment, the outer wall of the distal portion is generally cylindrical.
In another preferred embodiment, the blood testing device further comprises a proximal portion between the proximal end of the blood testing device and the proximal end of the intermediate portion. In a further embodiment, the proximal portion comprises a hollow, central chamber surrounded by an outer wall, and the proximal portion is configured to mate with a blood containing apparatus. In a further embodiment, the blood containing apparatus is selected from the group consisting of a syringe and the introducer part of an intravascular access apparatus. In a further embodiment, the outer wall of the proximal portion is generally cylindrical.
In another preferred embodiment, the hollow, central chamber of the intermediate portion and the hollow, central chamber of the distal portion comprise generally rectangular inferior parts that communicate with each other and that are configured to accept a test strip. In a further particularly preferred embodiment, the hollow, central chamber of the distal portion further comprises one or more than one ridge axially along the proximal to distal axis. In another embodiment, the outer wall of the intermediate portion is substantially transparent.
In another embodiment, the distal end cap is an integral part of the distal portion of the blood testing device.
In another embodiment, the distal end cap is removably affixed to the distal portion of the blood testing device.
In another embodiment, the distal end cap further comprises one or more than one second opening to allow the venting of air externally out of the distal portion of the blood testing device.
In another preferred embodiment, the inner membrane is a semipermeable member. In another embodiment, the inner membrane comprises one or more than one vent.
In another embodiment, the outer wall of the intermediate portion comprises one or more than one vent.
In another embodiment, the inner membrane comprises an opening configured to allow passage of a test strip from the distal portion of the blood testing device into the intermediate portion of the blood testing device.
In another embodiment, the intermediate portion is integrally affixed to an introducer portion of an intravascular access apparatus. In a further embodiment the intermediate portion is configured to affix to an introducer portion of an intravascular access apparatus.
In another preferred embodiment, the distal end of the blood testing device is integrally affixed to a blood collection apparatus. In a further embodiment, the distal end of the blood testing device is configured to affix to a blood collection apparatus. In one embodiment, the blood collection apparatus may be a syringe.
In another preferred embodiment, the intermediate portion is either integrally affixed or configured to affix to an introducer portion of an intravascular access apparatus, and the distal end is either integrally affixed or configured to affix to a blood collection apparatus. In one embodiment, the blood collection apparatus may be a syringe.
In another embodiment, the present invention is a blood testing apparatus comprising a plurality of interconnected blood testing devices according to the present invention.
In another embodiment, the present invention is a method for testing blood for the presence or for the amount of one or more than one constituent, or for testing blood to determine the level of one or more than one parameter, or for testing blood for a combination of the preceding. The method comprises the steps of, first, providing a blood testing device according to the present invention, a test strip comprising a proximal end and a distal end, a test strip reader configured to accept the distal end of the test strip and a blood containing apparatus. Next, the blood testing device is affixed to the blood containing apparatus and blood present in the blood containing apparatus is allowed to enter into the intermediate portion of the blood testing device. Then, the distal end of the test strip is inserted into the test strip reader and the proximal end of the test strip is inserted into the intermediate portion of the blood testing device. Next, an operator uses information provided by the test strip reader to determine the presence or the amount of one or more than one constituent of the blood, or to determine the level of one or more than one parameter, or to determine a combination of the preceding. In one embodiment, the blood testing apparatus is selected from the group consisting of an intravascular access apparatus and a syringe. The blood testing device and blood containing apparatus can be affixed integrally.
In another embodiment, the method further comprises selecting a patient whose blood is to be tested and intravascularly accessing the patient's blood with the blood containing apparatus. In another embodiment, the method further comprises the step of discarding the blood testing device.
In a further embodiment, the one or more than one opening in the proximal end of the intermediate portion of the blood testing device comprises a flow valve. In still further embodiments, this flow valve may be a duck-bill valve or a flap valve. FIGURES
These and other features, aspects and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying figures where:
Figure 1 is a lateral perspective view of a blood testing device according to one embodiment of the present invention;
Figure 2 is a cross-sectional, lateral perspective view of the blood testing device shown in Figure 1; Figure 3 is a lateral perspective view of a blood testing device shown in Figure 1 attached to a standard intravascular access apparatus;
Figure 4 is a lateral perspective view of a semipermeable membrane forming part of the blood testing device of Figure 1; Figure 5 is a lateral perspective view of a blood testing device according to another embodiment of the present invention;
Figure 6 is a lateral perspective view of a blood testing device according to another embodiment of the present invention;
Figure 7 is a lateral perspective view of a blood testing device according to another embodiment of the present invention;
Figure 8 is a lateral perspective view of a blood testing apparatus comprising a plurality of interconnected blood testing devices according to the present invention;
Figure 9 is a cross-sectional, lateral perspective view of the blood testing device shown in Figure 1 according to another embodiment of the present invention; Figure 10A is a cross-sectional view of a duck bill valve forming part of the blood testing device of Figure 6, before insertion of a test strip;
Figure 1 OB is a cross-sectional view of a duck bill valve forming part of the blood testing device of Figure 6, after insertion of a test strip;
Figure 11 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention;
Figure 12 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention;
Figure 13 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention; Figure 14 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention;
Figure 15 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention;
Figure 16 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention; and
Figure 17 is a cross-section and cut-away lateral view of a blood testing device according to another embodiment of the present invention. Figure 18 is a cross-sectional, lateral perspective view of another embodiment of the blood testing device shown in Figure 1.
DESCRIPTION According to one embodiment of the present invention, there is provided a blood testing device for testing blood for the presence or for the amount of one or more than one constituent, such as glucose, cardiac enzymes or red cells, or for testing blood to determine the level of one or more than one parameter, such as pH, or for testing blood for a combination of the preceding. The blood testing device decreases the possibility of inaccurate blood test results due to test strip contamination, and decreases the risk of exposing an operator to pathogens present in the blood.
According to another embodiment of the present invention, there is provided a method for testing blood for the presence or for the amount of one or more than one constituent, such as glucose, cardiac enzymes or red cells, or for testing blood to determine the level of one or more than one parameter, such as pH, or for testing blood for a combination of the preceding. The method comprises providing a testing means that decreases the possibility of inaccurate blood test results due to test strip contamination, and decreases the risk of exposing an operator to pathogens present in the blood. These embodiments will be disclosed in greater detail in the following disclosure. Referring now to Figure 1, Figure 2 and Figure 3, there are shown, respectively, a lateral perspective view of a blood testing device 10 according to one embodiment of the present invention; a cross-sectional, lateral perspective view of a blood testing device 10 shown in Figure 1; and a lateral perspective view of a blood testing device 10 shown in Figure 1 combined with a intravascular access apparatus 100. As can be seen, in this embodiment the blood testing device 10 comprises a proximal end 12 and a distal end 14. Between the proximal end 12 and the distal end 14, the blood testing device 10 further comprises a proximal portion 16, a distal portion 18, and an intermediate portion 20 between the proximal portion and the distal portion.
The proximal portion 16 comprises a proximal end 22 and a distal end 24 and, between the proximal end 22 and the distal end 24, further comprises a hollow, central chamber 26 surrounded by an outer wall 28 having a long axis in the proximal to distal direction. The outer wall 28 of the proximal portion 16 is configured to mate with the distal end of a blood containing apparatus, such as a syringe (not shown) or the introducer part 102 of an intravascular access apparatus 100, as shown in Figure 3. Preferably, the outer wall 28 of the proximal portion 16 is configured to mate with the distal end of the introducer part of a standard intravascular access apparatus, such as an Introcan® Safety™ IN Catheter (B. Braun Medical Inc., Bethlehem, PA US) or other standard intravascular access apparatus, and, therefore, the outer wall 28 of the proximal portion 16 will vary in configuration depending on the intravascular access apparatus that will be used in conjunction with the blood testing device 10 of the present invention, as will be understood by those with skill in the art with reference to this disclosure. In a preferred embodiment, as shown in Figure 1 and Figure 2, the outer wall 28 of the proximal portion 16 comprises a generally tapered proximal-most part 30 and a generally cylindrical distal-most part 32. The proximal-most part 30 of the outer wall 28 preferably further comprises one or more than one opening 34 allowing the hollow, central chamber 26 to communicate externally, or when combined with a blood containing apparatus, to communicate with the blood containing part of the blood containing apparatus. The one or more than one opening 34 is configured to allow the passage of blood that is present in the blood containing apparatus into the hollow, central chamber 26 of the proximal portion 16.
The intermediate portion 20 comprises a proximal end 36 and a distal end 38 and, between the proximal end 36 and the distal end 38, comprises a hollow, central chamber 40 surrounded by an outer wall 42 having a long axis in the proximal to distal direction.
Preferably, the outer wall 42 of the intermediate portion 20 is generally cylindrical, though other configurations are also suitable, as will be understood by those with skill in the art with reference to this disclosure. The proximal end 36 of the intermediate portion 20 comprises one or more than one opening 44 allowing the hollow, central chamber 40 of the intermediate portion 20 to communicate with the hollow, central chamber 26 of the proximal portion 16.
The passage of test strip 104 through the inner membrane 66 may create a small air leak that results in the encapsulated blood slowly dripping out of the proximal portion 16. This may be most evident if the hollow, central chamber40 completely fills with blood. As shown in Figure 18, optionally, the one or more than one opening 44 may comprise a one-way flow valve 118 which permits blood to flow into the intermediate portion 20, but restricts blood from flowing back through the proximal portion 16. Any valve that restricts blood to a substantially one-way flow will function as optional flow valve 118. Examples of valves suitable for such use include a duck-bill valve, and a flap valve.
The distal portion 18 comprises a proximal end 48 and a distal end 46 and, between the proximal end 48 and the distal end 46, comprises a hollow, central chamber 50 surrounded by an outer wall 52 with a central axis in the proximal to distal direction. Preferably, the outer wall 52 of the distal portion 18 is generally cylindrical, though other configurations are also suitable, as will be understood by those with skill in the art with reference to this disclosure.
The hollow, central chamber 50 has a sufficient size and suitable shape to receive a test strip 104 or other test apparatus inserted into the hollow, central chamber 50 from the distal end 14 of the blood testing device 10 toward the proximal end 12. As used in this disclosure, the term "test strip" is understood to include other test apparatuses that are not in linear strip form but are suitable for use with the blood testing device 10 of the present invention. Therefore, the configuration of the hollow, central chamber 50 of the distal portion 18 will depend upon the configuration of the test strip to be used, as will be understood by those with skill in the art with reference to this disclosure. Suitable test strips include chemical test strips, such as One Touch® FastTake® (LifeScan, Inc., Milpitas, CA US) and electrochemical test strips, such as
Precision QID (MediSense, Bedford, MA US).
In a particularly preferred embodiment, as shown in Figure 1, Figure 2 and Figure 3, the hollow, central chamber 50 of the distal portion 18, and the hollow, central chamber 40 of the intermediate portion 20, comprises generally rectangular (when viewed from an inferior direction), inferior part 54 and inferior part 56, respectively, as shown, that communicate with each other and that are configured to accept a test strip 104. The proximal end 58 of the outer wall of the inferior part 56 of the intermediate portion 20 is closed.
In another preferred embodiment, as shown in Figure 9, inferior part 54 of central chamber 50 of distal portionlδ further comprises one or more than one ridge 55 having a long axis in the proximal to distal direction. Ridge 55 acts a guide for test strip 104 in inferior part
54, and also helps to prevent blood from gaining access to the superior space in hollow, central chamber 50. Ridge 55 may extend for part or all of the length of central chamber 50, and may extend for part or all of the width of central chamber 50.
The outer wall 28 of the proximal portion 16, the outer wall 42 of the intermediate portion 20 and the outer wall 52 of the distal portion 18 preferably comprise a plastic material such as polycarbonate, that does not affect the constituents or parameters of blood being tested, though other materials are suitable as will be understood by those with skill in the art with reference to this disclosure. The material used is preferably inexpensive, as the blood testing device 10 is intended to be discarded after a single use, and is capable of being manufactured into the proper shape according to standard techniques lαiown to those with skill in the art, such as by injection molding. Further preferably, the material is either substantially transparent or at least sufficiently transparent to allow visual confirmation that blood is present in the hollow, central chamber 40 of the intermediate portion 20.
The distal end 14 of the blood testing device 10 further comprises a distal end cap 60. In one embodiment (not shown), the distal end cap 60 is an integral part of the distal portion 18 of the blood testing device 10, and of the same or of a different material as the outer wall 52 of the distal portion 18. In a preferred embodiment, as shown in Figure 1, Figure 2 and Figure 3, the distal end cap 60 is a separate part, removable from the distal portion 18, and comprises a resilient material such as natural or synthetic rubber that, when placed over the distal portion 18 of the blood testing device 10, tends to remain attached to the distal portion 18 of the blood testing device 10 due to the resilient nature of the material. In one embodiment, the distal end cap 60 further comprises at least a first opening 62 configured to snugly receive a test strip 104 inserted into the hollow, central chamber 50 of distal portion 18 of the blood testing device 10. Therefore, the configuration of the first opening 62 in the distal end cap 60 will depend upon the configuration of the test strip to be used, as will be understood by those with skill in the art with reference to this disclosure. In a preferred embodiment, the first opening 62 is generally slit-like, as shown in Figure 1, Figure 2 and Figure 3. The first opening 62 can comprise a simple opening into the hollow, central chamber 50 of the distal portion 18, as shown, or can comprise a valve, such as a duck bill valve 65 as shown in Figure 10A and Figure 10B. In a particularly preferred embodiment, as shown in Figure 1, Figure 2 and Figure 3, the distal portion 18 and the intermediate portion 20 each comprises the generally rectangular, inferior part 54 and 56 and the long axis of the first opening 62 is a slit that is aligned perpendicular to the direction of insertion of the long axis of the test strip 104 into the distal portion 18.
The distal end cap 60 can comprise a semipermeable membrane, as shown in Figure 11, that allows the selective passage of air out of the distal portion 18, while retaining the fluid and cellular components of blood within the distal portion 18. The semipermeable membrane can comprise any suitable material, such as Porex T3 #X-7744, (Porex Medical Products Group, Fairburn, GA US) or Type TTTP Isopore Membrane (Millipore Corporation, Bedford, MA US), though other material is also suitable as will be understood by those with skill in the art with reference to this disclosure.
Additionally preferably, and particularly when the distal end cap 60 does not comprise a semipermeable membrane, the distal end cap 60 comprises a vent of one or more than one second opening 64 to allow the venting of air externally out of the distal portion 18 of the blood testing device 10. The second opening 64 can be any suitable configuration, such as generally slit-like, as shown in Figure 1, as will be understood by those with skill in the art with reference to this disclosure. Alternatively, or additionally, as shown in Figure 13, the outer wall 52 of the distal portion 18 can comprise one or more than one vent 53. In one preferred embodiment, the blood testing device 10 further comprises an inner membrane 66 separating the distal end 38 of the hollow, central chamber 40 of the intermediate portion 20 from the proximal end 48 of the hollow, central chamber 50 of the distal portion 18. In a preferred embodiment, the inner membrane 66 is a semipermeable member. In another embodiment, the inner membrane 66 is not permeable but comprises one or more than one vent (not shown). Alternately, or additionally, as shown in Figure 13 and Figure 15, the outer wall
42 of the intermediate portion 20 can comprise one or more than one vent 43.
The inner membrane 66 comprises any suitable material, such as rubber or Porex T3 #X-7744, (Porex Medical Products Group, Fairburn, GA US), and can additionally be treated to be hydrophobic, as will be understood by those with skill in the art with reference to this disclosure.
Referring now to Figure 4, there is shown a lateral perspective view of one embodiment of an inner membrane 66 forming part of the embodiment of the blood testing device 10 shown in Figure 1, Figure 2 and Figure 3. The inner membrane 66 allows the selective passage of air through the inner membrane 66 between the distal end 38 of the hollow, central chamber 40 of the intermediate portion 20 and the proximal end 48 of the hollow, central chamber 50 of the distal portion 18, while preventing the passage of the fluid and cellular components of blood through the inner membrane 66.
The inner membrane 66 is further configured to allow passage of the test strip 104 from the distal portion 18 of the blood testing device 10 into the intermediate portion 20 of the blood testing device 10. For example, as shown in Figure 12, the inner membrane 66 can comprise a slit 67 aligned with the first opening 62 in the distal end cap 60. In a further embodiment, the inner membrane 66 can comprise a perforation (not shown) aligned with the first opening 62 in the distal end cap 60. In that embodiment the perforation can be constructed so that it is breached by the insertion of test strip 104.
In a preferred embodiment, as shown in Figure 1, Figure 2 and Figure 3, the intermediate portion 20 and the distal portion 18 each comprise the generally rectangular, inferior part 54 and 56 and the first opening 62 is a slit that is aligned perpendicular to the direction of insertion of the long axis of the test strip 104 into the distal portion 18, and the inner membrane 66 has an inferior extension 68 that further divides the inferior part 54 of the distal portion 18 from the inferior part 56 of the intermediate portion 20.
When a test strip is inserted through the distal end cap 60 and into the hollow, central chamber 50 of the inferior part 54 of the distal portion 18, the inferior extension 68 of the inner membrane 66 is displaced proximally, permitting the test strip to be further inserted into inferior part 56 of the intermediate portion 20, and allowing blood in the hollow, central chamber 40 of the intermediate portion 20 to contact the proximal end 106 of the test strip 104. Referring now to Figure 5, Figure 14, and Figure 15, there is shown lateral perspective views of a blood testing device 10 according to another embodiment of the present invention.
As can be seen, in these embodiments, the blood testing device 10 is manufactured without a proximal portion 16 and with the intermediate portion 20 integrally affixed to the distal end of the introducer part 102 of a standard intravascular access apparatus 100. In these embodiments, the blood testing device 10 and introducer part 102 of an intravascular access apparatus 100 are inserted intravascularly and are removed as a unit, as will be understood by those with skill in the art with reference to this disclosure.
As will be understood by those with skill in the art with reference to this disclosure, as the test strip is inserted through the distal end cap 60 and into the hollow, central chamber 50, the pressure within central chamber 50 will increase. If no pressure compensation system has been included in the blood testing device for amelioration of this pressure increase, depending upon the nature of the material chosen for the inner membrane 66, a corresponding increase in the pressure within the central chamber 40 of the intermediate portion 20 may result. If no pressure compensation system has been included for equalization of pressure within central chamber 40, a small amount of blood may be expelled through the one or more than one opening 34 of the proximal-most part 30 of outer wall 28 of proximal portion 16. This may be undesirable to the health care worker inserting the test strip. As the test strip is further inserted into inferior part 56 of the intermediate portion 20, an additional increase in pressure within central chamber 40 will occur, increasing the likelihood of escape of blood through opening 34.
A preferred embodiment of a pressure compensation system is as shown in Figure 1, Figure 2, and Figure 4, in which inner membrane 66 is a semipermeable member, comprising an inferior extension 68, and distal end cap 60 comprises a resilient material such as natural or synthetic rubber, and a vent of one or more than one second opening 64. As test strip 104 is inserted into blood testing device 10, this embodiment of the pressure compensation system allows pressure to equalize, resulting in little escape of blood from the intermediate portion into the distal portion, and no escape of blood from the blood testing device 10. Additionally preferably, central chamber 50 of distal portion 18 comprises one or more than one ridge 55 reducing the amount of blood that enters central chamber 50.
Another embodiment of a pressure compensation system, as shown in Figure 11, comprises a distal end cap 60 comprising a semipermeable membrane that allows the selective passage of air out of the distal portion 18, together with inner membrane 66 being a semipermeable member, comprising an inferior extension 68. In this embodiment, second opening 64 is not required.
Another embodiment of a pressure compensation system comprises a distal end cap 60 comprising an integral part of the distal portion 18 of the blood testing device 10, and of the same or of a different material as the outer wall 52 of the distal portion 18, together with inner membrane 66 being a semipermeable member, comprising an inferior extension 68. In this embodiment, second opening 64 is located either on the distal end cap, or one or more than one vent 53 is located on outer wall52.
Another embodiment of a pressure compensation system comprises an inner membrane 66 which is not permeable but comprises one or more than one vent (not shown). Alternately, or additionally, the outer wall 42 of the intermediate portion 20 can comprise one or more than one vent 43. In this embodiment, distal end cap 60 may optionally comprise (I) a resilient material such as natural or synthetic rubber, and a vent of one or more than one second opening 64 in the end cap, or the outer wall 52 of distal portion 18 can comprise one or more than one vent 53, (ii) a semipermeable membrane that allows the selective passage of air out of the distal portion 18, or (iii) an integral part of the distal portion 18 of the blood testing device 10, and of the same or of a different material as the outer wall 52 of the distal portion 18, and one or more than one second opening 64 in the end cap, or the outer wall 52 of distal portion 18 can comprise one or more than one vent 53. It is also possible to ameliorate the pressure increase caused by the insertion of the tests strip 104 through a pressure compensation valve. Referring now to Figure 6, there is shown a lateral perspective view of a blood testing device 10 according to another embodiment of the present invention. As can be seen, in this embodiment, the blood testing device 10 comprises a distal end cap 60 where the first opening 62 comprises a duck bill valve 65, shown in cross- section in Figure 10A before a test strip 104 is inserted, and shown in cross-section in Figure 10B after a test strip 104 is inserted, the sides of which adjoin and seal together when no test strip 104 is present and which separate upon insertion of a test strip to permit insertion of the test strip into the hollow, central chamber 40 of the intermediate portion 20. In this embodiment of a pressure compensation system, the equalization of pressure is accomplished by the collapse of the structure of the duck bill valve, as is shown in Figure 10B after the test strip 104 is inserted, and as will be understood by those with skill in the art with reference to this disclosure. Accordingly, in this embodiment opening 64 in end cap 60 and inner membrane 66 are not needed. Having thus described several embodiments of a pressure compensation system, it will now be understood by those with skill in the art with reference to this disclosure that a pressure compensation system may be constructed with various combinations of the described components, as further shown in Figures 11 through 17.
Referring now to Figure 7 and Figure 17, there is shown a lateral perspective view of a blood testing device 10 according to two other embodiments of the present invention. As can be seen, in these embodiments, the blood testing device 10 is manufactured integrally affixed to the side of a syringe 108 by connecting either the intermediate portion 20 of a blood testing device 10, as disclosed above, directly to the side of the syringe 108, as in Figure 7, or the inner membrane 66 directly to the side of the syringe 108, as in Figure 17, the interior of syringe 108 thus becoming the intermediate portion 20. Other blood collection devices could be used, as will be understood by those with skill in the art with reference to this disclosure.
It would also be possible to use a pressure compensation valve in either embodiment, and eliminate the inner membrane. In these embodiments, the syringe 108 is used to draw blood from a blood source and the blood testing device 10 is used to test the blood within the syringe 108 without having too expel the blood from the syringe 108. The blood testing device
10 can also be affixed to the distal end of the plunger of a syringe 108 where the plunger has a central channel in communication with the intermediate portion 20 of the blood testing device 10 (not shown).
In another embodiment, the present invention includes a blood testing apparatus 110 comprising a plurality of interconnected blood testing devices 10 according to the present invention, to allow multiple test strips to be read from blood in the same blood containing apparatus 110. Referring now to Figure 8, there is shown a lateral perspective view of such a blood testing apparatus 110. As can be seen, in this embodiment, the blood testing apparatus 110 comprises a proximal end 112 configured to mate with an intravascular access apparatus 100, a distal end 114 configured to mate with a syringe 108, a hollow, central chamber 116 between the proximal end and the distal end, and a plurality of blood testing devices 10 according to the present invention, each blood testing device 10 joined to the hollow, central chamber 116. In a preferred embodiment, the distal end 114 is configured to mate with the proximal end of a standard flash plug or the proximal end of a syringe 108 (as shown). This embodiment allows blood from one source to be tested using a plurality of blood testing devices 10 according to the present invention, as will be understood by those with skill in the art with reference to this disclosure.
According to another embodiment, referring now to Figure 11, blood testing device 10 takes the place of a standard flash plug, the proximal end 12 of blood testing device 10 is configured to mate with the introducer part 102 of a intravascular access apparatus 100, as shown in Figure 11, and additionally optionally the distal end 14 of blood testing device 10 may be configured to mate (not shown) integrally or removably with a blood collection device such as syringe 108.
According to another embodiment of the present invention, there is provided a method for testing blood for the presence or for the amount of various constituents, such as glucose, cardiac enzymes or red cells, or for testing blood to determine the level of various parameters, such as pH, or for testing blood for a combination of the preceding. The method comprises providing a blood testing device according to the present invention. The method additionally comprises providing a test strip, a test strip reader and a blood containing apparatus, such as an intravascular access apparatus or a syringe. The test strip can be any suitable test strip with a proximal end configured to be inserted into the distal end cap of the blood testing device. The test strip reader can be any suitable test strip reader configured to accept the distal end of the test strip and, after accepting the distal end, to provide the desired information on blood that has contacted the proximal end of the test strip. The blood containing apparatus can be any intravascular access apparatus suitable for accessing a vascular structure and suitable for joining to the proximal end of a blood testing device according to the present invention, or any other suitable blood containing apparatus as will be understood by those with skill in the art with reference to this disclosure. The blood testing device can be provided with or without the test strip inserted through the distal end cap and into the distal portion and intermediate portion of the blood testing device. If the blood testing device is provided with the test strip inserted through the distal end cap and into the distal portion and intermediate portion of the blood testing device, then the combined blood testing device and test strip can be provided with the distal end of the test strip already inserted into the test strip reader. Further, the blood testing device, whether or not combined with the test strip or with the test strip and test strip reader together, can be provided having its proximal end already inserted into the distal end of the blood containing apparatus or can be provided without its proximal end already inserted into the distal end of the blood containing apparatus. As will be understood by those with skill in the art with reference to this disclosure, the blood containing apparatus, blood testing device, test strip and test strip reader are assembled together during the method of the present invention, and can be assembled in various orders. In a particularly preferred embodiment, the distal end of the test strip is inserted into the test strip reader, and then the proximal end of the test strip is inserted into the distal end cap of the blood testing device and through or around the inner membrane after blood has entered the intermediate portion of the blood testing device.
Next, a patient is selected who is to have his or her blood tested. If the blood containing apparatus is an intravascular access apparatus, the patient is prepped in a standard manner and intravascular access is begun using the intravascular access apparatus according to standard techniques, as will be understood by those with skill in the art with reference to this disclosure. If the proximal end of the blood testing device was not already inserted into the distal end of the intravascular access apparatus before obtaining intravascular access, then the proximal end of the blood testing device is inserted into the distal end of the intravascular access apparatus, such as by replacing the flash plug on the intravascular access apparatus with the proximal portion of the blood testing device. Preferably, the proximal end of the blood testing device is inserted into the distal end of the intravascular access apparatus before insertion of the intravascular access apparatus. Alternately, a blood testing device is provided according to the present invention, without a proximal portion and with the intermediate portion integrally affixed to the distal end of the introducer portion of a standard intravascular access apparatus.
Once vascular access is obtained and the blood testing device and the intravascular access apparatus are combined, blood from the patient's accessed vascular structure will pass through the one or more than one opening in the proximal end of the proximal portion into the hollow, central chamber of the proximal portion and, then, into the hollow, central chamber of the intermediate portion, or will pass directly into the hollow, central chamber of the intermediate portion if the blood testing device is integrally affixed to the intravascular access apparatus. Air that is present in the hollow, central chamber of the proximal portion, if present, and hollow, central chamber of the intermediate portion passes through the inner membrane into the hollow, central chamber of the distal portion and then, externally. If not already combined, the distal end of the test strip is inserted into the test strip reader and the proximal end of the test strip is inserted into the distal end cap, through the distal portion and into the intermediate portion of the blood testing device. The blood in the hollow, central chamber of the intermediate portion will, then, contact the proximal end of the test strip. Next, the distal end of the test strip is inserted into an appropriate test strip reader, if not done previously. The operator uses information provided by the test strip reader, such as a digital readout or visual indicator, to determine the presence or the amount of one or more than one constituent of the blood, such as glucose, cardiac enzymes or red cells, or to determine the level of one or more than one parameter, such as pH, or to determine a combination of the preceding.
In one embodiment, the operator withdraws the blood testing device from the distal end of the intravascular access apparatus before using the test strip reader. In another embodiment, the blood testing device with an inserted test strip is removed from the intravascular access apparatus and an operator proceeds to establish intravascular access while the distal end of the test strip is being inserted into an appropriate testing apparatus, so that no time is being lost in establishing intravascular access while blood testing is being performed. In a preferred embodiment, the introducer part of the intravascular access apparatus with the blood testing device still inserted into the distal end are removed together, and an operator proceeds to establish intravascular access while the proximal end of the test strip is being inserted into distal end of the blood testing device, further increasing efficiency in establishing intravascular access while blood testing is being performed. In a particularly preferred embodiment, the blood testing device provided for use in this method is the embodiment shown in Figure 5, and as will be understood by those with skill in the art with reference to this disclosure, removing the blood testing device necessarily removes the introducer part of the intravascular access apparatus from the vascular structure as the blood testing device is integrally affixed to the distal end of the introducer part of the intravascular access apparatus. After the operator makes the appropriate determinations, the blood testing device with the test strip still inserted is removed from the test strip reader and, preferably with the introducer portion if being used with an introducer portion, is discarded in an appropriate manner as a biohazard. As can be appreciated by those with skill in the art with reference to this disclosure, the present method decreases the possibility of inaccurate blood test results due to test strip contamination, decreases the time necessary to analyze blood being tested from standard methods, decreases the risk of exposure of the operator to pathogens present in the blood, and simplifies disposal of the equipment used in testing the blood.
According to another embodiment of the present invention, there is provided a method for testing blood for the presence or for the amount of various constituents, such as glucose, cardiac enzymes or red cells, or for testing blood to determine the level of various parameters, such as pH, or for testing blood for a combination of the preceding. The method comprises providing a blood testing apparatus according to the present invention, where the blood testing apparatus comprises a plurality of blood testing devices according to the present invention joined to a common central chamber that is configured at the proximal end to combine removably or to be affixed with a blood containing apparatus, and to communicate with the blood containing part of the blood containing apparatus. As will be understood by those with skill in the art, with reference to this disclosure, the method corresponds to the method disclosed above, except that blood test strips can be inserted into the distal end caps of each blood testing device on the blood testing apparatus, expanding the capacity to test the blood. According to another embodiment of the present invention, there is provided a method for testing blood for the presence or for the amount of various constituents, such as glucose, cardiac enzymes or red cells, or for testing blood to determine the level of various parameters, such as pH, or for testing blood for a combination of the preceding. The method comprises using a blood containing apparatus, such as a syringe, other than an intravascular access apparatus. In this method, blood is drawn into the blood containing apparatus other than by obtaining intravascular access directly through the distal end of the blood containing apparatus, such as by attaching the blood containing apparatus directly to an intravascular access apparatus or blood containing vial and drawing blood into the blood containing apparatus from that source.
Although the present invention has been discussed in considerable detail with reference to certain preferred embodiments, other embodiments are possible. Therefore, the scope of the appended claims should not be limited to the description of preferred embodiments contained in this disclosure.

Claims

CLAIMS WHAT IS CLAIMED IS:
1. A blood testing device for testing blood for the presence or for the amount of one or more than one constituent, or for testing blood to determine the level of one or more than one parameter, or for testing blood for a combination of the preceding, the blood testing device comprising: a) a proximal end of the blood testing device and a distal end of the blood testing device; b) an intermediate portion between the proximal end of the blood testing device and the distal end of the blood testing device; and c) a pressure compensation system to regulate the pressure in the intermediate portion; and where the intermediate portion comprises a proximal end of the intermediate portion comprising one or more than one opening, a distal end of the intermediate portion and, between the proximal end of the intermediate portion and the distal end of the intermediate portion, comprises a hollow, central chamber surrounded by an outer wall.
2. The blood testing device of claim 1, where the pressure compensation system comprises a distal portion between the proximal end of the blood testing device and the distal end of the blood testing device, an inner membrane separating the intermediate portion from the distal portion; and where the distal portion comprises a proximal end of the distal portion and a distal end of the distal portion and, between the proximal end of the distal portion and the distal end of the distal portion, comprises a hollow, central chamber surrounded by an outer wall.
3. The blood testing device of claim 1, where the pressure compensation system comprises a pressure compensation valve.
4. The blood testing device of claim 3, where the pressure compensation valve is a duck bill valve.
5. The blood testing device of claim 2, further comprising a distal end cap at the distal end of the blood testing device comprising a first opening configured to receive a test strip.
6. The blood testing device of claim 1, where the outer wall of the intermediate portion is generally cylindrical.
7. The blood testing device of claim 2, where the outer wall of the distal portion is generally cylindrical.
8. The blood testing device of claim 1, further comprising a proximal portion between the proximal end of the blood testing device and the proximal end of the intermediate portion; where the proximal portion comprises a hollow, central chamber surrounded by an outer wall; and where the proximal portion is configured to mate with a blood containing apparatus.
9. The blood testing device of claim 8, where the blood containing apparatus is selected from the group consisting of a syringe and the introducer part of an intravascular access apparatus.
10. The blood testing device of claim 8, where the outer wall of the proximal portion is generally cylindrical.
11. The blood testing device of claim 2, where the hollow, central chamber of the intermediate portion and the hollow, central chamber of the distal portion comprise generally rectangular inferior parts that communicate with each other and that are configured to accept a test strip.
12. The blood testing device of claim 11, where the hollow, central chamber of the distal portion further comprises one or more than one ridge axially along the proximal to distal axis.
13. The blood testing device of claim 1, where the outer wall of the intermediate portion is substantially transparent.
14. The blood testing device of claim 5, where the distal end cap is an integral part of the distal portion of the blood testing device.
15. The blood testing device of claim 5, where the distal end cap is removably affixed to the distal portion of the blood testing device.
16. The blood testing device of claim 5, where the distal end cap further comprises one or more than one second opening to allow the venting of air externally out of the distal portion of the blood testing device.
17. The blood testing device of claim 5, where the distal end cap is a semipermeable member.
18. The blood testing device of claim 5, where the distal end cap is a non-permeable member.
19. The blood testing device of claim 2, where the inner membrane is a semipermeable member.
20. The blood testing device of claim 2, where the inner membrane comprises one or more than one vent.
21. The blood testing device of claim 1, where the outer wall of the intermediate portion comprises one or more than one vent.
22. The blood testing device of claim 2, where the inner membrane comprises an opening configured to allow passage of a test strip from the distal portion of the blood testing device into the intermediate portion of the blood testing device.
23. The blood testing device of claim 1, where the intermediate portion is integrally affixed to an introducer portion of an intravascular access apparatus.
24. The blood testing device of claim 1, where the intermediate portion is configured to affix to an introducer portion of an intravascular access apparatus.
25. The blood testing device of claim 1, where the distal end is integrally affixed to a blood collection apparatus.
26. The blood testing device of claim 1, where the distal end is configured to affix to a blood collection apparatus.
27. The blood testing device of claim 23, where the distal end is integrally affixed to a blood collection apparatus.
28. The blood testing device of claim 23, where the distal end is configured to affix to a blood collection apparatus.
29. The blood testing device of claim 28, where the blood collection apparatus is a syringe.
30. The blood testing device of claim 24, where the distal end is integrally affixed to a blood collection apparatus.
31. The blood testing device of claim 24, where the distal end is configured to affix to a blood collection apparatus.
32. The blood testing device of claim 31, where the blood collection apparatus is a syringe.
33. A blood testing apparatus comprising a plurality of interconnected blood testing devices according to claim 1.
34. A method for testing blood for the presence or for the amount of one or more than one constituent, or for testing blood to determine the level of one or more than one parameter, or for testing blood for a combination of the preceding, the method comprising the steps of: a) providing a blood testing device according to claim 1, a test strip comprising a proximal end and a distal end, a test strip reader configured to accept the distal end of the test strip and a blood containing apparatus; b) affixing the blood testing device to the blood containing apparatus and allowing blood present in the blood containing apparatus to enter into the intermediate portion of the blood testing device; c) inserting the distal end of the test strip into the test strip reader and the proximal end of the test strip into the intermediate portion of the blood testing device; and d) using information provided by the test strip reader to determine the presence or the amount of one or more than one constituent of the blood, or to determine the level of one or more than one parameter, or to determine a combination of the preceding.
35. The method of claim 34, where the blood containing apparatus provided in step a) is selected from the group consisting of an intravascular access apparatus and a syringe.
36. The method of claim 34, further comprising selecting a patient whose blood is to be tested and intravascularly accessing the patient's blood with the blood containing apparatus.
37. The method of claim 34, where the blood testing device and blood containing apparatus are affixed integrally in step b).
38. The method of claim 34, further comprising the step of discarding the blood testing device after step c).
39. Means for testing blood for the presence or for the amount of one or more than one constituent, or for testing blood to determine the level of one or more than one parameter, or for testing blood for a combination of the preceding, the means comprising: a) a proximal end of the blood testing device and a distal end; b) an intermediate portion between the proximal end and the distal end; c) end means to receive a test strip; and d) means to compensate for pressure changes within the intermediate portion; and where the intermediate portion comprises a proximal end of the intermediate portion comprising one or more than one opening, a distal end of the intermediate portion and, between the proximal end of the intermediate portion and the distal end of the intermediate portion, comprises a hollow, central chamber surrounded by an outer wall.
40. A method for testing blood for the presence or for the amount of one or more than one constituent, or for testing blood to determine the level of one or more than one parameter, or for testing blood for a combination of the preceding, the method comprising the steps of: a) providing a blood testing means, a test strip comprising a proximal end and a distal end, a test strip reader configured to accept the distal end of the test strip and a blood containing apparatus; b) affixing the blood testing means to the blood containing apparatus and allowing blood present in the blood containing apparatus to enter into the intermediate portion of the blood testing device; c) inserting the proximal end of the test strip into the intermediate portion of the blood testing means and the distal end of the test strip into the test strip reader; and d) using information provided by the test strip reader to determine the presence or the amount of one or more than one constituent of the blood, or to determine the level of one or more than one parameter, or to determine a combination of the preceding.
41. The blood testing device of claim 1, where the one or more than one opening in the proximal end of the intermediate portion comprises a flow valve.
42. The blood testing device of claim 41, where the flow valve is a duck-bill valve.
43. The blood testing device of claim 41, where the flow valve is a flap valve.
44. The means for testing blood of claim 39, where the one or more than one opening in the proximal end of the intermediate portion comprises a flow valve.
45. The means for testing blood of claim 44, where the flow valve is a duck-bill valve.
46. The means for testing blood of claim 44, where the flow valve is a flap valve.
PCT/US2002/008818 2001-04-06 2002-03-20 Blood testing device WO2002082052A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002443076A CA2443076A1 (en) 2001-04-06 2002-03-20 Blood testing device
BR0208698-0A BR0208698A (en) 2001-04-06 2002-03-20 Blood test device
US10/474,082 US20040116830A1 (en) 2001-08-24 2002-03-20 Blood testing deivce
JP2002579774A JP2005503538A (en) 2001-04-06 2002-03-20 Blood tester
AU2002254330A AU2002254330A1 (en) 2001-04-06 2002-03-20 Blood testing device
EP02723558A EP1411820A2 (en) 2001-04-06 2002-03-20 Blood testing device

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28195701P 2001-04-06 2001-04-06
US60/281,957 2001-04-06
PCT/US2001/026666 WO2002080763A2 (en) 2001-04-06 2001-08-24 Blood testing device
USPCT/US01/26666 2001-08-24

Publications (2)

Publication Number Publication Date
WO2002082052A2 true WO2002082052A2 (en) 2002-10-17
WO2002082052A3 WO2002082052A3 (en) 2004-02-19

Family

ID=26680563

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/008818 WO2002082052A2 (en) 2001-04-06 2002-03-20 Blood testing device

Country Status (6)

Country Link
EP (1) EP1411820A2 (en)
JP (1) JP2005503538A (en)
AU (1) AU2002254330A1 (en)
BR (1) BR0208698A (en)
CA (1) CA2443076A1 (en)
WO (1) WO2002082052A2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007041063A2 (en) 2005-09-30 2007-04-12 Intuity Medical, Inc. Fluid sample transport devices and methods
US8919605B2 (en) 2009-11-30 2014-12-30 Intuity Medical, Inc. Calibration material delivery devices and methods
US8969097B2 (en) 2005-06-13 2015-03-03 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit-volume correction and feedback control
US9060723B2 (en) 2005-09-30 2015-06-23 Intuity Medical, Inc. Body fluid sampling arrangements
US9095292B2 (en) 2003-03-24 2015-08-04 Intuity Medical, Inc. Analyte concentration detection devices and methods
US9549701B2 (en) 2010-07-19 2017-01-24 Becton, Dickinson And Company Device and method for collecting a blood sample
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
US9782114B2 (en) 2011-08-03 2017-10-10 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
US10330667B2 (en) 2010-06-25 2019-06-25 Intuity Medical, Inc. Analyte monitoring methods and systems
US10383556B2 (en) 2008-06-06 2019-08-20 Intuity Medical, Inc. Medical diagnostic devices and methods
US10433780B2 (en) 2005-09-30 2019-10-08 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US10729386B2 (en) 2013-06-21 2020-08-04 Intuity Medical, Inc. Analyte monitoring system with audible feedback
US10772550B2 (en) 2002-02-08 2020-09-15 Intuity Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8747333B2 (en) * 2010-07-15 2014-06-10 Becton, Dickinson And Company Blood test strip and an intravenous catheter system

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4989606A (en) * 1987-01-30 1991-02-05 Minnesota Mining And Manufactoring Company Intravascular blood gas sensing system
US6151516A (en) * 1995-06-07 2000-11-21 Masimo Laboratories Active pulse blood constituent monitoring
US6198952B1 (en) * 1998-10-30 2001-03-06 Medtronic, Inc. Multiple lens oxygen sensor for medical electrical lead

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4989606A (en) * 1987-01-30 1991-02-05 Minnesota Mining And Manufactoring Company Intravascular blood gas sensing system
US6151516A (en) * 1995-06-07 2000-11-21 Masimo Laboratories Active pulse blood constituent monitoring
US6198952B1 (en) * 1998-10-30 2001-03-06 Medtronic, Inc. Multiple lens oxygen sensor for medical electrical lead

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10772550B2 (en) 2002-02-08 2020-09-15 Intuity Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US9095292B2 (en) 2003-03-24 2015-08-04 Intuity Medical, Inc. Analyte concentration detection devices and methods
US10226208B2 (en) 2005-06-13 2019-03-12 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US9366636B2 (en) 2005-06-13 2016-06-14 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US11419532B2 (en) 2005-06-13 2022-08-23 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US8969097B2 (en) 2005-06-13 2015-03-03 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit-volume correction and feedback control
US9060723B2 (en) 2005-09-30 2015-06-23 Intuity Medical, Inc. Body fluid sampling arrangements
EP1928299A4 (en) * 2005-09-30 2010-05-26 Intuity Medical Inc Fluid sample transport devices and methods
US10433780B2 (en) 2005-09-30 2019-10-08 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US9380974B2 (en) 2005-09-30 2016-07-05 Intuity Medical, Inc. Multi-site body fluid sampling and analysis cartridge
US10842427B2 (en) 2005-09-30 2020-11-24 Intuity Medical, Inc. Body fluid sampling arrangements
EP1928299A2 (en) * 2005-09-30 2008-06-11 Intuity Medical, Inc. Fluid sample transport devices and methods
WO2007041063A2 (en) 2005-09-30 2007-04-12 Intuity Medical, Inc. Fluid sample transport devices and methods
US9839384B2 (en) 2005-09-30 2017-12-12 Intuity Medical, Inc. Body fluid sampling arrangements
US10441205B2 (en) 2005-09-30 2019-10-15 Intuity Medical, Inc. Multi-site body fluid sampling and analysis cartridge
US7887494B2 (en) 2005-09-30 2011-02-15 Intuity Medical, Inc. Fluid sample transport devices and methods
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
US11045125B2 (en) 2008-05-30 2021-06-29 Intuity Medical, Inc. Body fluid sampling device-sampling site interface
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
US10383556B2 (en) 2008-06-06 2019-08-20 Intuity Medical, Inc. Medical diagnostic devices and methods
US11399744B2 (en) 2008-06-06 2022-08-02 Intuity Medical, Inc. Detection meter and mode of operation
US11553860B2 (en) 2008-06-06 2023-01-17 Intuity Medical, Inc. Medical diagnostic devices and methods
US11002743B2 (en) 2009-11-30 2021-05-11 Intuity Medical, Inc. Calibration material delivery devices and methods
US8919605B2 (en) 2009-11-30 2014-12-30 Intuity Medical, Inc. Calibration material delivery devices and methods
US9897610B2 (en) 2009-11-30 2018-02-20 Intuity Medical, Inc. Calibration material delivery devices and methods
US10330667B2 (en) 2010-06-25 2019-06-25 Intuity Medical, Inc. Analyte monitoring methods and systems
US9549701B2 (en) 2010-07-19 2017-01-24 Becton, Dickinson And Company Device and method for collecting a blood sample
US11672452B2 (en) 2011-08-03 2023-06-13 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11051734B2 (en) 2011-08-03 2021-07-06 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11382544B2 (en) 2011-08-03 2022-07-12 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US9782114B2 (en) 2011-08-03 2017-10-10 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US10729386B2 (en) 2013-06-21 2020-08-04 Intuity Medical, Inc. Analyte monitoring system with audible feedback

Also Published As

Publication number Publication date
EP1411820A2 (en) 2004-04-28
AU2002254330A1 (en) 2002-10-21
BR0208698A (en) 2004-03-30
CA2443076A1 (en) 2002-10-17
WO2002082052A3 (en) 2004-02-19
JP2005503538A (en) 2005-02-03

Similar Documents

Publication Publication Date Title
US20040116830A1 (en) Blood testing deivce
CN104107054B (en) For collecting the medical apparatus of biological sample
WO2002082052A2 (en) Blood testing device
AU2010271420B2 (en) Blood sampling device with gas permeable vent
AT397610B (en) DEVICE FOR TAKING BODY LIQUIDS
JP6298151B2 (en) Biological fluid sampling device
JP2018020243A (en) Biological fluid sampling device
US20050061700A1 (en) Medical device package, kit and associated methods
EP3138494A1 (en) Flashback blood collection needle
KR102634850B1 (en) A Collection Module
EP2254472B1 (en) Flashback blood collection needle
BR112014009409B1 (en) CARTRIDGE AND BLOOD COLLECTION SYSTEM
US20040102718A1 (en) Blood testing device
EP1385416A2 (en) Blood testing device
EP4233724A2 (en) Biological fluid micro-sample management device
DE102021203637A1 (en) Input chamber for loading a sampling device into a microfluidic device, microfluidic device, method of operating and method of making a microfluidic device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2443076

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10474082

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002579774

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002723558

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002723558

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002723558

Country of ref document: EP